Fr. 147.00

Immunotherapy and Biomarkers in Neurodegenerative Disorders

Inglese · Tascabile

Spedizione di solito entro 6 a 7 settimane

Descrizione

Ulteriori informazioni

This practical volume examines a number of topicsthat explore the current status of immunotherapy and diagnostic markers forneurodegenerative disorders. With a focus on Alzheimer's disease, the firstsections of the book examine immunotherapeutic approaches for theaforementioned disease as well as for Parkinson's disease and Huntington's disease,amongst others. The last section of the book covers the importance of biomarkertechniques to catch these diseases early enough for the treatments to be mostuseful. Written for the Methods inPharmacology and Toxicology series, this book contains the kind of detaileddescriptions and implementation advice that will offer a smooth transition intothe lab.
Authoritative and useful, Immunotherapy and Biomarkers inNeurodegenerative Disorders aims to aid in the continued progress in thedevelopment of novel immune-based drugs and diagnostic tools for thesedevastating brain diseases.

Sommario

Immunotherapy Against Amyloid-beta in Alzheimer's Disease: AnOverview.- Active Immunization Against the Amyloid-beta Peptide.- ImmunotherapyAgainst N-Truncated Amyloid-beta Oligomers.- Immunotherapy Against Amyloid-betaProtofibrils: Opportunities and Challenges.- Immunotherapy Against -SynucleinPathology.- Extracellular -Synuclein as a Target for Immunotherapy.- Immunotherapyof Parkinson's Disease.- TauImmunotherapy.- Active and Passive Immunotherapy Against Tau: Effectsand Potential Mechanisms.- Immunotherapy on Experimental Models forHuntington's Disease.- Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.- VolumetricMRI as a Diagnostic Tool in Alzheimer's Disease.- PET Imaging as a DiagnosticTool in Alzheimer´s Disease.- lpha-Synuclein as a Diagnostic Biomarker forParkinson's Disease.- Imaging as a Diagnostic Tool in Parkinson's Disease.- MassSpectrometry-Based Proteomics in Biomarker Discovery for NeurodegenerativeDiseases.

Riassunto

With a focus on Alzheimer’s disease, the firstsections of the book examine immunotherapeutic approaches for theaforementioned disease as well as for Parkinson’s disease and Huntington’s disease,amongst others.

Dettagli sul prodotto

Con la collaborazione di Marti Ingelsson (Editore), Martin Ingelsson (Editore), Lannfelt (Editore), Lannfelt (Editore), Lars Lannfelt (Editore)
Editore Springer, Berlin
 
Lingue Inglese
Formato Tascabile
Pubblicazione 01.01.2018
 
EAN 9781493980789
ISBN 978-1-4939-8078-9
Pagine 289
Dimensioni 180 mm x 15 mm x 253 mm
Peso 574 g
Illustrazioni X, 289 p. 40 illus., 32 illus. in color.
Serie Methods in Pharmacology and Toxicology
Methods in Pharmacology and To
Methods in Pharmacology and Toxicology
Categorie Scienze naturali, medicina, informatica, tecnica > Medicina > Farmacia

B, Pharmacology, Biomedical and Life Sciences, Pharmacology/Toxicology, monoclonal antibodies, Parkinson’s disease, Therapeutic antibodies, Immunotherapeutic targets

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.